100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached 4.2 TrustPilot
logo-home
Summary

Samenvatting Geneeskundige ziekteleer 3

Rating
-
Sold
1
Pages
208
Uploaded on
06-10-2022
Written in
2020/2021

zelf geschreven samrnvatting aan de hand van colleges/boeken/aantekeningen. eigen draai aan gegeven. heeft mij enorm geholpen en nog steeds.

Institution
Course











Whoops! We can’t load your doc right now. Try again or contact support.

Written for

Institution
Study
Course

Document information

Uploaded on
October 6, 2022
Number of pages
208
Written in
2020/2021
Type
Summary

Subjects

Content preview

Geneeskundige
ziekteleer van
de huisdieren III



anne swanenberg

,Inhoud
Problemen bij de drachtige hond en kat ................................................................................................. 3
Fysiologische veranderingen drachtige teef ....................................................................................... 3
Fysiologische veranderingen bij de kat ............................................................................................... 6
Sterfte / abortus .................................................................................................................................. 6
Zieke teef tijdens de dracht:.............................................................................................................. 10
Andere afwijkingen: .......................................................................................................................... 11
Foetale afwijkingen ........................................................................................................................... 12
Medicatie tijdens de dracht: ............................................................................................................. 13
Dystocie ............................................................................................................................................. 14
Indicaties voor keizersnede: .............................................................................................................. 21
Vanaf en tot wanneer zijn pups levensvatbaar? ............................................................................... 21
Dystocie bij de kat ............................................................................................................................. 22
Post partum problemen .................................................................................................................... 22
metroraggie ....................................................................................................................................... 24
Problemen met melkklier – postpartum ........................................................................................... 25
neonatologie ......................................................................................................................................... 27
Postnatale zorg door de fokker bij de geboorte ............................................................................... 27
Neonatale zorg door de dierenarts ................................................................................................... 30
Veel voorkomende afwijkingen bij intacte teef en poes....................................................................... 35
Veel voorkomende afwijkingen bij de intacte reu en de kater ............................................................ 43
Infertiliteit.............................................................................................................................................. 52
echografie van het voortplantingsstelsel .............................................................................................. 61
voortplanting stelsel van het vrouwelijke dier .................................................................................. 61
Het mannelijk voortplantingsstelsel...................................................................................................... 67
Klinische voeding ................................................................................................................................... 70
Intensive care voeding ...................................................................................................................... 70
Chronische nierinsufficiëntie patiënten ............................................................................................ 75
Proteïn loosing nefropathie............................................................................................................... 79
Dermatologie ..................................................................................................................................... 81
Critical care ............................................................................................................................................ 83
Shock ..................................................................................................................................................... 85
vloeistoftherapie ............................................................................................................................... 88
Stabilisatie dyspnee ............................................................................................................................... 94
Abdominale distensie – acuut abdomen ............................................................................................... 98
Critical care – voedingssondes ............................................................................................................ 102

1

,Oftalmologie ........................................................................................................................................ 104
Processen orbita .............................................................................................................................. 104
Aandoeningen van het nasolacrimaal apparaat.............................................................................. 110
Conjunctiva ...................................................................................................................................... 112
Cornea ............................................................................................................................................. 112
Corpus cilliaire ................................................................................................................................. 116
lens .................................................................................................................................................. 120
Uvea................................................................................................................................................. 122
Vitreum ............................................................................................................................................ 125
Retina .............................................................................................................................................. 125
Oncologie............................................................................................................................................. 128
Vaak voorkomende tumoren .......................................................................................................... 133
Tumoren van de huid ...................................................................................................................... 136
Endocriene tumoren........................................................................................................................ 141
Osteosarcoom ................................................................................................................................. 143
Gastro- intestinale tumoren ............................................................................................................ 144
Oncologie- Farmacotherapie bij tumoren ........................................................................................... 147
Tumorkinetiek ................................................................................................................................. 147
Pyodermie in alle glorie ....................................................................................................................... 152
Dermatologische spoed....................................................................................................................... 163
Huidaandoeningen van de neusspiegel............................................................................................... 164
Depigmentatie zonder verlies van netvormig patroon ....................................................................... 167
Auto immune en immuun gemedieerde huidaandoeningen .............................................................. 168
Feliene dermatologie .......................................................................................................................... 174
Oncologie: medische beeldvorming .................................................................................................... 181
oncopathologie.................................................................................................................................... 184
Respiratiestelsel - tumoren ............................................................................................................. 184
Spijsverteringsstelsel- tumoren ...................................................................................................... 187
Urinewegen- tumoren ..................................................................................................................... 192
Genitaalstelsel- tumoren ................................................................................................................. 193
Hart -tumoren ................................................................................................................................. 197
circulatie stelsel - tumoren .............................................................................................................. 197
Integument - tumoren ..................................................................................................................... 198
Heamolymfatisch stelsel -tumoren ................................................................................................. 202
Bewegingsstelsel ............................................................................................................................. 203
Endocrien stelsel -tumoren ............................................................................................................. 205

2

, Centraal zenuwstelsel- tumoren ..................................................................................................... 205
pancreastumoren ............................................................................................................................ 206
Tumor galwegen .............................................................................................................................. 206
Cases ................................................................................................................................................ 206



Problemen bij de drachtige hond en kat
Fysiologische veranderingen drachtige teef




Teef is mono-oestrisch. Zie ook semester 1 2e master. Vaginaal bloedverlies wordt veroorzaakt door
een stijging in oestrogenen. Dag 1 van de cyclus is vaak dag 1 van het bloed verlies (ofwel 10 dagen
voor de LH piek). Tijdens de pro-oestrus dus bloedverlies, mannetjes aantrekken en verhoornde
cellen. pro-oestrus zullen oestrogenen dalen en LH piek zal intreden op dag 0. 2 dagen na de LH iek
zien we ovulatie. Tijdens de LH piek zien we hogere progesteronwaarden door de luteïnisatie zal
plaatsvind IN de follikels. Na de ovulatie vormen follikels CL met abrupte stijging in progesteron tot
20-40 ng/ml. 9 weken dracht, dus op dag 63 NA de ovulatie zal meestal de partus intreden
progesteron zal in de 2e helft van de dracht een lagere waarde aannemen, niet ernstig want de
dracht wordt ondersteund door relaxine wat geproduceerd wordt door de placenta van de puppys.
Prolactine is een hormoon dat in de 2e helft van dr dracht zal stijgen > belangrijk voor de
melkproductie (prolactine zal stijgen als progesteron daalt = reflectoir). Prolactine ondersteunt ook
de corpora lutea die aanwezig zijn zodat progesteron hogere waarden blijft houden.




➔ Cervix moet gesloten zijn, omdat anders kiemen kunnen opklimmen. Placenta produceert
geen progesteron. 1e helft onafhankelijke productie, 2e helft ondersteund door prolactine.
Ook LH ondersteunt progesteron productie.

3
$12.57
Get access to the full document:

100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached


Also available in package deal

Get to know the seller

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
anneswa Universiteit Antwerpen
Follow You need to be logged in order to follow users or courses
Sold
86
Member since
9 year
Number of followers
61
Documents
0
Last sold
5 months ago

3.4

7 reviews

5
2
4
0
3
4
2
1
1
0

Recently viewed by you

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Frequently asked questions